Incyte (NASDAQ:INCY) underwent analysis by 9 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. The 12-month price targets, analyzed by analysts, offer insights with an average target of $67.11, a high estimate of $88.00, and a low estimate of $48.00. This upward trend is evident, with the current average reflecting a 3.07% increase from the previous average price target of $65.11. Investigating…